Screening for drug-resistant TB hotspots in Namibia
Part of Infections clinical trials.
This study tries to find more cases of drug-resistant tuberculosis (TB that doesn’t respond to usual medicines) by checking people in specific regions, households, hospitals, and high-risk “hotspots.” It may help detect TB earlier and link more people to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or the person you’re asking for) must have been diagnosed with drug-resistant TB in Namibia
- You must be located in Khomas, Otjozondjupa, or Ohangwena regions for the screening
- If you’re a household member of a person with drug-resistant TB, you may be included
- If you’re a hospital visitor of a person with drug-resistant TB, you may be included
- If you’re a community member at a known transmission “hotspot,” you may be included
- You must agree to participate by giving consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a community-based approach to improve tuberculosis (TB) monitoring and screening for immigrants who recently arrived from specific African and Asian countries. It aims to make TB checkups easier to access and understand.
This study looks at the types of drug-resistant tuberculosis (TB) bacteria spreading in Central Africa. By examining sputum samples from people with TB, researchers hope to better understand how resistant strains are transmitted, which can help improve treatment.
This study tests rapid TB screening and lab-style diagnostic methods to see how well they find TB disease and TB that is resistant to rifampin (a key TB drug). It may help doctors diagnose TB faster and more accurately, especially in people at higher risk.
This study uses next-generation gene testing to help manage active drug-resistant tuberculosis. It may help doctors choose the most appropriate treatment by better identifying the TB’s drug resistance.
This study looks for HIV drug resistance in people who have been on a specific first-line HIV medication (TLD) for at least 6 months and still have detectable virus. It aims to understand if resistance is developing so that better treatments can be planned.
This study screens people for tuberculosis (TB), a serious lung infection, using new testing methods. Researchers want to find TB cases early so people can get treatment before the disease becomes severe.
Hear when a new Tuberculosis, Multidrug-Resistant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.